COLL vs ROK · P/E 17, rev $181.9M vs P/E 48, rev $8.34B
Collegium Pharmaceutical Inc (COLL) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. Revenue was up 0.9% from 2024-09-30 to 2025-09-30. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the COLL and ROK stock pages for the full models.
Not investment advice.